514797-97-8 Usage
General Description
2-Bromo-5-chloro-3-fluoropyridine is a chemical compound with the molecular formula C5H2BrClFNO. It is a pyridine derivative with bromine, chlorine, and fluorine substituents. 2-Bromo-5-chloro-3-fluoropyridine is commonly used as a building block in the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals. It is known for its versatile reactivity, making it an important intermediate for the production of various organic compounds. Additionally, 2-Bromo-5-chloro-3-fluoropyridine is also used as a reagent in organic synthesis and as a starting material for the development of new chemical entities. Its unique chemical properties and applications make it a valuable compound in the field of chemical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 514797-97-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,1,4,7,9 and 7 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 514797-97:
(8*5)+(7*1)+(6*4)+(5*7)+(4*9)+(3*7)+(2*9)+(1*7)=188
188 % 10 = 8
So 514797-97-8 is a valid CAS Registry Number.
InChI:InChI=1/C5H2BrClFN/c6-5-4(8)1-3(7)2-9-5/h1-2H
514797-97-8Relevant articles and documents
PYRROLOPYRIMIDINE DERIVATIVES AS NR2B NMDA RECEPTOR ANTAGONISTS
-
Paragraph 0323, (2016/04/09)
Disclosed are chemical entities of formula I: [INSERT CHEMICAL FORMULA HERE] wherein X, Y, Z, R1, R3, R4, R5 and R6 are defined herein, as NR2B subtype selective receptor antagonists. Also disclosed are pharmaceutical compositions comprising a chemical entity of formula I, and methods of treating various diseases and disorders associated with NR2B antagonism, e.g., diseases and disorders of the CNS, such as depression, by administering a chemical entity of formula I.
Certain Chemical Entities, Compositions, and Methods
-
Page/Page column 36, (2008/12/07)
Provided are certain chemical entities, and methods of use to modulate skeletal myosin, skeletal actin, skeletal tropomyosin, skeletal troponin C, skeletal troponin I, skeletal troponin T, and skeletal muscle, including fragments and isoforms thereof, as well as the skeletal sarcomere, and methods of use in the treatment of muscle weakness and/or cachexia, as part of a rehabilitation or conditioning exercise regimen, or in the treatment of fraility, post-polio syndrome, obesity, sarcopenia, wasting syndrome, muscle spasm, and other indications.